APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha V

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Integrin Alpha V Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchIntegrin Alpha V Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha V Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Integrin Alpha V Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha V Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha V Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Integrin Alpha V market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Integrin Alpha V market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Integrin Alpha V market include Merck & Co Inc, Biogen Inc, Vascular Pharmaceuticals Inc, SciFluor Life Sciences LLC, Morphic Therapeutic Inc, Merck KGaA, MedImmune LLC, Factor Therapeutics Ltd and BioMAS Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Integrin Alpha V market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Integrin Alpha V and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Integrin Alpha V revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Integrin Alpha V market.

Integrin Alpha V Segment by Company

Merck & Co Inc

Biogen Inc

Vascular Pharmaceuticals Inc

SciFluor Life Sciences LLC

Morphic Therapeutic Inc

Merck KGaA

MedImmune LLC

Factor Therapeutics Ltd

BioMAS Ltd

Integrin Alpha V Segment by Type

MK-0429

C-16Y

AC-301

264-RAD

Others

Integrin Alpha V Segment by Application

Ophthalmology

Respiratory

Metabolic Disorders

Infectious Disease

Others

Integrin Alpha V Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Integrin Alpha V status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Integrin Alpha V key companies, revenue, market share, and recent developments.

3. To split the Integrin Alpha V breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Integrin Alpha V market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Integrin Alpha V significant trends, drivers, influence factors in global and regions.

6. To analyze Integrin Alpha V competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha V market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha V and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha V.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Integrin Alpha V industry.

Chapter 3: Detailed analysis of Integrin Alpha V company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Integrin Alpha V in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Integrin Alpha V in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Integrin Alpha V Industry Trends Table 2. Integrin Alpha V Industry Drivers Table 3. Integrin Alpha V Industry Opportunities and Challenges Table 4. Integrin Alpha V Industry Restraints Table 5. Global Integrin Alpha V Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Integrin Alpha V Revenue Share by Company (2021-2026) Table 7. Global Integrin Alpha V Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Integrin Alpha V Key Company Manufacturing Base & Headquarters Table 9. Global Integrin Alpha V Company, Product Type & Application Table 10. Global Integrin Alpha V Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Integrin Alpha V by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of MK-0429 Table 15. Significant Companies of C-16Y Table 16. Significant Companies of AC-301 Table 17. Significant Companies of 264-RAD Table 18. Significant Companies of Others Table 19. Global Integrin Alpha V Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Integrin Alpha V Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Integrin Alpha V Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Integrin Alpha V Sales Value Share by Type (2021-2026) Table 23. Global Integrin Alpha V Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Ophthalmology Table 25. Significant Companies of Respiratory Table 26. Significant Companies of Metabolic Disorders Table 27. Significant Companies of Infectious Disease Table 28. Significant Companies of Others Table 29. Global Integrin Alpha V Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Integrin Alpha V Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Integrin Alpha V Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Integrin Alpha V Sales Value Share by Application (2021-2026) Table 33. Global Integrin Alpha V Sales Value Share by Application (2027-2032) Table 34. Global Integrin Alpha V Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Integrin Alpha V Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Integrin Alpha V Sales Value Share by Region (2021-2026) Table 37. Global Integrin Alpha V Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Integrin Alpha V Sales Value Share by Region (2027-2032) Table 39. Global Integrin Alpha V Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Integrin Alpha V Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Integrin Alpha V Sales Value Market Share by Country (2021-2026) Table 42. Global Integrin Alpha V Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Integrin Alpha V Sales Value Market Share by Country (2027-2032) Table 44. Merck & Co Inc Company Information Table 45. Merck & Co Inc Business Overview Table 46. Merck & Co Inc Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Merck & Co Inc Integrin Alpha V Product Portfolio Table 48. Merck & Co Inc Recent Development Table 49. Biogen Inc Company Information Table 50. Biogen Inc Business Overview Table 51. Biogen Inc Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Biogen Inc Integrin Alpha V Product Portfolio Table 53. Biogen Inc Recent Development Table 54. Vascular Pharmaceuticals Inc Company Information Table 55. Vascular Pharmaceuticals Inc Business Overview Table 56. Vascular Pharmaceuticals Inc Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio Table 58. Vascular Pharmaceuticals Inc Recent Development Table 59. SciFluor Life Sciences LLC Company Information Table 60. SciFluor Life Sciences LLC Business Overview Table 61. SciFluor Life Sciences LLC Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio Table 63. SciFluor Life Sciences LLC Recent Development Table 64. Morphic Therapeutic Inc Company Information Table 65. Morphic Therapeutic Inc Business Overview Table 66. Morphic Therapeutic Inc Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Morphic Therapeutic Inc Integrin Alpha V Product Portfolio Table 68. Morphic Therapeutic Inc Recent Development Table 69. Merck KGaA Company Information Table 70. Merck KGaA Business Overview Table 71. Merck KGaA Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck KGaA Integrin Alpha V Product Portfolio Table 73. Merck KGaA Recent Development Table 74. MedImmune LLC Company Information Table 75. MedImmune LLC Business Overview Table 76. MedImmune LLC Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. MedImmune LLC Integrin Alpha V Product Portfolio Table 78. MedImmune LLC Recent Development Table 79. Factor Therapeutics Ltd Company Information Table 80. Factor Therapeutics Ltd Business Overview Table 81. Factor Therapeutics Ltd Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Factor Therapeutics Ltd Integrin Alpha V Product Portfolio Table 83. Factor Therapeutics Ltd Recent Development Table 84. BioMAS Ltd Company Information Table 85. BioMAS Ltd Business Overview Table 86. BioMAS Ltd Integrin Alpha V Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. BioMAS Ltd Integrin Alpha V Product Portfolio Table 88. BioMAS Ltd Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Integrin Alpha V Product Image Figure 2. Global Integrin Alpha V Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrin Alpha V Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. MK-0429 Image Figure 8. C-16Y Image Figure 9. AC-301 Image Figure 10. 264-RAD Image Figure 11. Others Image Figure 12. Global Integrin Alpha V Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Integrin Alpha V Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Integrin Alpha V Sales Value Share by Type (2021-2032) Figure 15. Ophthalmology Image Figure 16. Respiratory Image Figure 17. Metabolic Disorders Image Figure 18. Infectious Disease Image Figure 19. Others Image Figure 20. Global Integrin Alpha V Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Integrin Alpha V Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Integrin Alpha V Sales Value Share by Application (2021-2032) Figure 23. Global Integrin Alpha V Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Integrin Alpha V Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Integrin Alpha V Sales Value (2021-2032) & (US$ Million) Figure 26. North America Integrin Alpha V Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Integrin Alpha V Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Integrin Alpha V Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Integrin Alpha V Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Integrin Alpha V Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Integrin Alpha V Sales Value (2021-2032) & (US$ Million) Figure 32. South America Integrin Alpha V Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Integrin Alpha V Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Integrin Alpha V Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Integrin Alpha V Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Integrin Alpha V Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Integrin Alpha V Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • MK-0429
  • C-16Y
  • AC-301
  • 264-RAD
  • Others
Applications
  • Ophthalmology
  • Respiratory
  • Metabolic Disorders
  • Infectious Disease
  • Others
Companies covered
  • Merck & Co Inc
  • Biogen Inc
  • Vascular Pharmaceuticals Inc
  • SciFluor Life Sciences LLC
  • Morphic Therapeutic Inc
  • Merck KGaA
  • MedImmune LLC
  • Factor Therapeutics Ltd
  • BioMAS Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Integrin Alpha V Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Integrin Alpha V Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Integrin Alpha V Market Dynamics
  1. 2.1 Integrin Alpha V Industry Trends
  2. 2.2 Integrin Alpha V Industry Drivers
  3. 2.3 Integrin Alpha V Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha V Industry Restraints
3 Integrin Alpha V Market by Company
  1. 3.1 Global Integrin Alpha V Company Revenue Ranking in 2025
  2. 3.2 Global Integrin Alpha V Revenue by Company (2021-2026)
  3. 3.3 Global Integrin Alpha V Company Ranking (2024-2026)
  4. 3.4 Global Integrin Alpha V Company Manufacturing Base and Headquarters
  5. 3.5 Global Integrin Alpha V Company Product Type and Application
  6. 3.6 Global Integrin Alpha V Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Integrin Alpha V Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Integrin Alpha V Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Integrin Alpha V Market by Type
  1. 4.1 Integrin Alpha V Type Introduction
  2. 4.1.1 MK-0429
  3. 4.1.2 C-16Y
  4. 4.1.3 AC-301
  5. 4.1.4 264-RAD
  6. 4.1.5 Others
  7. 4.2 Global Integrin Alpha V Sales Value by Type
  8. 4.2.1 Global Integrin Alpha V Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Integrin Alpha V Sales Value by Type (2021-2032)
  10. 4.2.3 Global Integrin Alpha V Sales Value Share by Type (2021-2032)
5 Integrin Alpha V Market by Application
  1. 5.1 Integrin Alpha V Application Introduction
  2. 5.1.1 Ophthalmology
  3. 5.1.2 Respiratory
  4. 5.1.3 Metabolic Disorders
  5. 5.1.4 Infectious Disease
  6. 5.1.5 Others
  7. 5.2 Global Integrin Alpha V Sales Value by Application
  8. 5.2.1 Global Integrin Alpha V Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Integrin Alpha V Sales Value by Application (2021-2032)
  10. 5.2.3 Global Integrin Alpha V Sales Value Share by Application (2021-2032)
6 Integrin Alpha V Regional Value Analysis
  1. 6.1 Global Integrin Alpha V Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Integrin Alpha V Sales Value by Region (2021-2032)
  3. 6.2.1 Global Integrin Alpha V Sales Value by Region: 2021-2026
  4. 6.2.2 Global Integrin Alpha V Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Integrin Alpha V Sales Value (2021-2032)
  7. 6.3.2 North America Integrin Alpha V Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Integrin Alpha V Sales Value (2021-2032)
  10. 6.4.2 Europe Integrin Alpha V Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Integrin Alpha V Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Integrin Alpha V Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Integrin Alpha V Sales Value (2021-2032)
  16. 6.6.2 South America Integrin Alpha V Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Integrin Alpha V Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Integrin Alpha V Sales Value Share by Country, 2025 VS 2032
7 Integrin Alpha V Country-level Value Analysis
  1. 7.1 Global Integrin Alpha V Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Integrin Alpha V Sales Value by Country (2021-2032)
  3. 7.2.1 Global Integrin Alpha V Sales Value by Country (2021-2026)
  4. 7.2.2 Global Integrin Alpha V Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Integrin Alpha V Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Integrin Alpha V Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Integrin Alpha V Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Integrin Alpha V Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Integrin Alpha V Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Integrin Alpha V Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Integrin Alpha V Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Integrin Alpha V Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Integrin Alpha V Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Integrin Alpha V Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Integrin Alpha V Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Integrin Alpha V Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Integrin Alpha V Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Integrin Alpha V Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Integrin Alpha V Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Integrin Alpha V Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Integrin Alpha V Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Integrin Alpha V Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Integrin Alpha V Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Integrin Alpha V Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Integrin Alpha V Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Integrin Alpha V Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Integrin Alpha V Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Integrin Alpha V Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Integrin Alpha V Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Integrin Alpha V Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Integrin Alpha V Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Integrin Alpha V Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Integrin Alpha V Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Integrin Alpha V Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co Inc
  2. 8.1.1 Merck & Co Inc Company Information
  3. 8.1.2 Merck & Co Inc Business Overview
  4. 8.1.3 Merck & Co Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co Inc Integrin Alpha V Product Portfolio
  6. 8.1.5 Merck & Co Inc Recent Developments
  7. 8.2 Biogen Inc
  8. 8.2.1 Biogen Inc Company Information
  9. 8.2.2 Biogen Inc Business Overview
  10. 8.2.3 Biogen Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biogen Inc Integrin Alpha V Product Portfolio
  12. 8.2.5 Biogen Inc Recent Developments
  13. 8.3 Vascular Pharmaceuticals Inc
  14. 8.3.1 Vascular Pharmaceuticals Inc Company Information
  15. 8.3.2 Vascular Pharmaceuticals Inc Business Overview
  16. 8.3.3 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio
  18. 8.3.5 Vascular Pharmaceuticals Inc Recent Developments
  19. 8.4 SciFluor Life Sciences LLC
  20. 8.4.1 SciFluor Life Sciences LLC Company Information
  21. 8.4.2 SciFluor Life Sciences LLC Business Overview
  22. 8.4.3 SciFluor Life Sciences LLC Integrin Alpha V Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio
  24. 8.4.5 SciFluor Life Sciences LLC Recent Developments
  25. 8.5 Morphic Therapeutic Inc
  26. 8.5.1 Morphic Therapeutic Inc Company Information
  27. 8.5.2 Morphic Therapeutic Inc Business Overview
  28. 8.5.3 Morphic Therapeutic Inc Integrin Alpha V Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Morphic Therapeutic Inc Integrin Alpha V Product Portfolio
  30. 8.5.5 Morphic Therapeutic Inc Recent Developments
  31. 8.6 Merck KGaA
  32. 8.6.1 Merck KGaA Company Information
  33. 8.6.2 Merck KGaA Business Overview
  34. 8.6.3 Merck KGaA Integrin Alpha V Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck KGaA Integrin Alpha V Product Portfolio
  36. 8.6.5 Merck KGaA Recent Developments
  37. 8.7 MedImmune LLC
  38. 8.7.1 MedImmune LLC Company Information
  39. 8.7.2 MedImmune LLC Business Overview
  40. 8.7.3 MedImmune LLC Integrin Alpha V Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune LLC Integrin Alpha V Product Portfolio
  42. 8.7.5 MedImmune LLC Recent Developments
  43. 8.8 Factor Therapeutics Ltd
  44. 8.8.1 Factor Therapeutics Ltd Company Information
  45. 8.8.2 Factor Therapeutics Ltd Business Overview
  46. 8.8.3 Factor Therapeutics Ltd Integrin Alpha V Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Factor Therapeutics Ltd Integrin Alpha V Product Portfolio
  48. 8.8.5 Factor Therapeutics Ltd Recent Developments
  49. 8.9 BioMAS Ltd
  50. 8.9.1 BioMAS Ltd Company Information
  51. 8.9.2 BioMAS Ltd Business Overview
  52. 8.9.3 BioMAS Ltd Integrin Alpha V Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioMAS Ltd Integrin Alpha V Product Portfolio
  54. 8.9.5 BioMAS Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst